McKinsey Says Generative AI in Healthcare Is Maturing — and Agentic AI Is the Next Bet
McKinsey’s latest look at healthcare AI suggests the market is moving beyond experimentation into more mature deployment. The next phase, it argues, is agentic AI — systems that can take multi-step actions rather than simply generate text.
The healthcare AI market is moving from novelty to operationalization. That is the core message behind the latest industry analysis: generative AI is no longer just a pilot project category, and health systems are starting to focus on measurable value, integration, and scale.
What makes this especially significant is the turn toward agentic AI. Unlike chat-style interfaces, agentic systems can orchestrate tasks across workflows — for example, collecting information, triggering follow-up steps, and coordinating across applications. In healthcare, that could mean much more than better note drafting; it could change how administrative and clinical processes are executed.
Still, maturity does not mean readiness for unrestricted deployment. Agentic systems introduce a new kind of operational risk because they act, not just suggest. That raises questions about oversight, auditability, liability, and where human approval must remain mandatory.
McKinsey’s framing is a useful signal of where vendor and buyer attention is heading, but health systems should resist the urge to buy “autonomy” before they have mastered data governance and workflow design. The near-term winners will likely be organizations that use AI to simplify tasks, not those that hand over decision-making wholesale.